Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

Based on data from 1.14 million vaccinations which have been administered, scientists from the University of Edinburgh have shown that both the BioNtech/Pfizer and Oxford vaccines are highly effective and that by the fourth week after receiving the initial dose shown to reduce the risk of hospitalisation from COVID-19 by up to 85% and 94%, respectively.

They report that by the fourth week after receiving the initial vaccination, those aged 80 years and over were shown to have an 81% reduction in hospitalisation risk, a combined result for data from those vaccinated with either the Oxford or BionTech/Pfizer vaccines.

Sarah Gilbert, Professor of Vaccinology, said:  

‘The real-world data from Scotland now provides evidence of high effectiveness of both the Oxford/AstraZeneca and BionTech/Pfizer vaccines in preventing hospitalisation in people over the age of 80, after a single dose, supporting our confidence in using this vaccine in adults of all ages.’ 

These data were gathered as part of the EAVE II project, which uses patient data to track the pandemic and the vaccine roll out in real time, with researchers from the Universities of Edinburgh, Strathclyde, Aberdeen, Glasgow and St Andrew’s and Public Health Scotland (PHS) analysing a dataset covering the entire Scottish population of 5.4 million. 

Andrew Pollard, Professor of Paediatric Infection and Immunity, and Chief Investigator on the Oxford vaccine trial, said: 

'We are delighted to see that the real-world evidence reported today from the University of Edinburgh which confirms that both the Oxford-AstraZeneca vaccine and the Pfizer vaccine have a very substantial impact against hospitalisation with COVID19 disease. Vaccines work. We now need to make sure that everyone everywhere is protected'

The news comes as real-world data from vaccination programmes around the world start to become available.

Teresa Lambe, Associate Professor and Jenner Investigator, concludes:

‘When we first started this journey, we could only hope that a year later, real world data would show this level of impact from our vaccine against hospitalisation from severe illness. It is a huge day for us all, especially the team who've worked so hard, and monumental in our battle against coronavirus.’

Similar stories

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

Oral paratyphoid vaccine to begin human trials

The University of Oxford in collaboration with the University of Maryland School of Medicine (UMSoM) has begun recruiting for a Phase I/II trial of a new paratyphoid vaccine in human volunteers in Oxford.

Oxford scientist named Australian of the Year in the UK

The Oxford Vaccine Group’s Lead Statistician, Professor Merryn Voysey, received the prestigious Australian of the Year in the UK award at a gala dinner recently.

Angelman syndrome: first patient to receive potential therapy in Oxford

Things that seemed impossible, only a few years ago, are happening today. The first patient in Europe and one of the first in the world was injected with a potential treatment, GTX-102, in a phase I/II clinical trial in Oxford.

New model for infant leukaemia announced

The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.

Why it's so hard to treat pain in infants

For decades physicians believed that premature babies didn’t experience pain. Here’s what doctors know now – and the innovative solutions being embraced by today's caregivers.